We compared the insulin sensitivity index (SI) measured by euglycemic clamping with the glucose infusion rate (GIR) and fasting insulin concentration. Euglycemic clamping was conducted at 2 insulin infusion rates (1.12 mU/kg/min and 2.24 mU/kg/min) in 45 patients with type 2 diabetes mellitus treated with diet or oral hypoglycemic drugs. Patients were 29 men and 16 women, 58±11 years of age, and either obese (body mass index [BMI] 25 kg/m
2, 17 patients) or nonobese (BMI<25 kg/m
2, 28 patients).
In obese patients, greater peripheral insulin concentrations (68±18 μU/m
l, 133±43 μU/m
l) than those of nonobese patients (55±13 μU/m
l, 98±27 μU/m
l) were required to maintain a quantitatively equivalent GIR (3.8±1.4 mg/kg/min, 7.1±2.1 mg/kg/min) to those of nonobese patients (4.1±1.8 mg/kg/min, 6.7±2.1 mg/kg/min). SI of obese patients (0.94±0.73±10
-3 dl /kgμmin/μU/m
l) did not differ from that of nonobese patients (0.92±0.57±10
-3dl /kgμmin/μU/m
l).
SI and GIR/IRI correlated (r=0.52, p<0.05) in obese patients, but not in nonobese patients. Obese patients had much higher fasting insulin (8.9±3.2 μU/m
l) than that of nonobese patients (6.9±2.4 μU/m
l) and fasting insulin concentration correlated with the reciprocal of SI (r=0.52, p<0.05) or reciprocal of GIR (r=0.69, p<0.01) at a fasting plasma glucose of<170 mg/dl.
In conclusion, we showed that a while GIR or SI of obese type 2 DM subjects did not differ from that of nonobese DM subjects, insulin resistance was increased more in obese patients than in nonobese patients. Peripheral insulin concentration must therefore be cousidered during clamping for evaluating SI, b) Fasting insulin concentration is useful as a surrogate for GIR or SI in obese type 2 DM subjects when insulin-glucose feedback is operative.
View full abstract